These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 18226561)
21. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Boulbou MS; Koukoulis GN; Makri ED; Petinaki EA; Gourgoulianis KI; Germenis AE Int J Cardiol; 2005 Jan; 98(1):39-44. PubMed ID: 15676164 [TBL] [Abstract][Full Text] [Related]
22. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome. López-Lerma I; Estrach MT J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of circulating vascular endothelial growth factor and soluble adhesion molecules as reliable predictors of native arteriovenous fistula thrombosis in chronic hemodialysis patients. Zohny SF; Abd el-Fattah M Clin Biochem; 2008 Oct; 41(14-15):1175-80. PubMed ID: 18692491 [TBL] [Abstract][Full Text] [Related]
24. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease. Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549 [TBL] [Abstract][Full Text] [Related]
25. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854 [TBL] [Abstract][Full Text] [Related]
27. Soluble adhesion molecules in end-stage renal disease: a predictor of outcome. Suliman ME; Qureshi AR; Heimbürger O; Lindholm B; Stenvinkel P Nephrol Dial Transplant; 2006 Jun; 21(6):1603-10. PubMed ID: 16476720 [TBL] [Abstract][Full Text] [Related]
28. The MTHFR 677 C/T polymorphism influences plasma levels of adhesion molecules and nitric oxide. Juo SH; Liao YC; Kuo CL; Wang Y; Huang CS; Chiang HC; Liu CS Thromb Res; 2008; 121(4):549-54. PubMed ID: 17707074 [TBL] [Abstract][Full Text] [Related]
29. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588 [TBL] [Abstract][Full Text] [Related]
30. Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial. Zwierska I; Walker RD; Choksy SA; Male JS; Pockley AG; Saxton JM J Vasc Surg; 2005 Dec; 42(6):1122-30. PubMed ID: 16376202 [TBL] [Abstract][Full Text] [Related]
31. Limb-specific and cross-transfer effects of arm-crank exercise training in patients with symptomatic peripheral arterial disease. Tew G; Nawaz S; Zwierska I; Saxton JM Clin Sci (Lond); 2009 Sep; 117(12):405-13. PubMed ID: 19388883 [TBL] [Abstract][Full Text] [Related]
32. Soluble endothelial cell adhesion molecules and their relationship to disease activity in Takayasu's arteritis. Tripathy NK; Chandran V; Garg NK; Sinha N; Nityanand S J Rheumatol; 2008 Sep; 35(9):1842-5. PubMed ID: 18597403 [TBL] [Abstract][Full Text] [Related]
33. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Adamopoulos S; Parissis J; Kroupis C; Georgiadis M; Karatzas D; Karavolias G; Koniavitou K; Coats AJ; Kremastinos DT Eur Heart J; 2001 May; 22(9):791-7. PubMed ID: 11350112 [TBL] [Abstract][Full Text] [Related]
34. Relative tolerance to upper- and lower-limb aerobic exercise in patients with peripheral arterial disease. Zwierska I; Walker RD; Choksy SA; Male JS; Pockley AG; Saxton JM Eur J Vasc Endovasc Surg; 2006 Feb; 31(2):157-63. PubMed ID: 16095931 [TBL] [Abstract][Full Text] [Related]
35. Soluble adhesion molecule profiling in preoperative infants with biliary atresia. Davenport M; Gonde C; Narayanaswamy B; Mieli-Vergani G; Tredger JM J Pediatr Surg; 2005 Sep; 40(9):1464-9. PubMed ID: 16150350 [TBL] [Abstract][Full Text] [Related]
36. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein. Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459 [TBL] [Abstract][Full Text] [Related]
37. Effects of marine n-3 fatty acids on circulating levels of soluble adhesion molecules in patients with chronic heart failure. Eschen O; Christensen JH; LA Rovere MT; Romano P; Sala P; Schmidt EB Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):45-51. PubMed ID: 20196969 [TBL] [Abstract][Full Text] [Related]
39. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease. Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047 [TBL] [Abstract][Full Text] [Related]
40. A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication. Collins P; Ford I; Ball D; Macaulay E; Greaves M; Brittenden J Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):266-73. PubMed ID: 16360327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]